Dr. Michael D. Bavlsik, MD

Dr. Bavlsik practices at Washington University Clinical Associates in Saint Louis, Missouri.

Dr. Bavlsik's NPI, 1295752756, was assigned on July 17, 2006. Dr. Bavlsik graduated from Rutgers Robert Wood Johnson Medical School in 1991. Dr. Bavlsik holds Missouri license 102863.

Dr. Bavlsik's primary practice is Washington University Clinical Associates, at 4921 Parkview Pl, Saint Louis, MO 63110 in Saint Louis City. The practice phone is (314) 333-4100.

Dr. Bavlsik's primary practice is Washington University Clinical Associates in Saint Louis, Missouri. Dr. Bavlsik is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Bavlsik to 5 more hospitals, 3 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bavlsik practices, 11 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bavlsik's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bavlsik is board certified in internal medicine by the American Board of Internal Medicine. Dr. Bavlsik is licensed in Missouri.

Dmand AI lists acid reflux, acute mini-stroke (TIA), acute sinusitis, acute skin infection, ADHD, alzheimer's disease, aneurysm and anxiety among the conditions Dr. Bavlsik treats.

CMS data shows 3,227 Medicare services from Dr. Bavlsik across 29 procedure codes in 2024, for 393 Medicare patients. Medicare paid $132,458 for them. Every service was in an office.

CMS counts 393 Medicare patients who saw Dr. Bavlsik in 2024. The largest group is 65 to 74, with 173 patients. 68% of them have high blood pressure, and 59% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bavlsik's median patient age at 68, with 48% women.

In 2024, Dr. Bavlsik wrote 13,943 Medicare Part D claims for 813 patients. 87% of them were for generic drugs. CMS names the drug for 13,051 of them, across 175 drugs with 11 or more claims each, at $1,314,850 in total drug cost. In 2023, CMS named 11,562 claims across 159 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bavlsik for performance year 2024, reported as part of a group. Dr. Bavlsik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bavlsik as offering telehealth.

CMS Open Payments shows 176 general payments to Dr. Bavlsik from 28 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 97% of the total. Astellas Pharma US Inc paid the most, $474.

Dr. Bavlsik graduated from Rutgers Robert Wood Johnson Medical School in 1991.

Dr. Bavlsik is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.